Stifel Maintains Buy on Compugen, Raises Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Willey has maintained a Buy rating on Compugen (NASDAQ:CGEN) and increased the price target from $3 to $4.
December 19, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel analyst Stephen Willey maintains a Buy rating on Compugen and raises the price target from $3 to $4, indicating a positive outlook on the stock.
The increase in price target by Stifel suggests a strong conviction in Compugen's potential, likely leading to increased investor confidence and a positive short term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100